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Abstract: African Americans (AAs) have a higher obesity risk than Whites; however, it is unclear if
appetite-related hormones and food intake are implicated. We examined differences in appetite-related
hormones, appetite, and food intake between AAs (n = 53) and Whites (n = 111) with overweight or
obesity. Participants were randomized into a control group or into supervised, controlled exercise
groups at 8 kcal/kg of body weight/week (KKW) or 20 KKW. Participants consumed lunch and dinner
at baseline and follow-up, with appetite and hormones measured before and after meals (except
leptin). At baseline, AAs had lower peptide YY (PYY; p < 0.01) and a blunted elevation in PYY after
lunch (p = 0.01), as well as lower ghrelin (p = 0.02) and higher leptin (p < 0.01) compared to Whites.
Despite desire to eat being lower and satisfaction being higher in AAs relative to Whites (p ≤ 0.03),
no racial differences in food intake were observed. Compared to Whites, leptin increased in the 8
KKW group in AAs (p = 0.01), yet no other race-by-group interactions were evident. Differences
in appetite-related hormones between AAs and Whites exist; however, their influence on racial
disparities in appetite, food intake, and obesity within this trial was limited.
Keywords: energy intake; food intake; satiety; race; exercise; physical activity; health disparities;
body composition; satiety quotient; visual analogue scales
1. Introduction
Obesity and related comorbidities are a common problem in westernized societies, with minority
racial groups being at increased risk. One racial group disproportionally affected by obesity includes
African Americans (AAs) [1]. Compared to Whites, AAs have an increased risk of obesity and
consequently experience higher rates of diabetes and cardiovascular disease [2–4].
Numerous studies sought to elucidate the mechanisms underlying these disparities by
investigating racial differences in energy homeostasis and associated modifiers. While some studies
showed that AAs exhibit lower energy expenditure than Whites [5,6], relatively few investigated
racial variations in the physiological control of appetite regulation and food intake. A handful of
studies report that, compared to Whites, concentrations of leptin are higher [7,8] and peptide YY
(PYY) [7,8] and ghrelin [9,10] are suppressed in AAs. Nevertheless, it is not known if AAs and
Whites present different concentrations of glucagon-like peptide-1 (GLP-1), an anorexigenic hormone
secreted primarily from intestinal L-cells, akin to PYY [11]. It is additionally unclear if disparities in
appetite-related hormones translate into differences in appetite perceptions and food intake. Two
studies reported that subjective appetite perceptions in AAs and Whites were similar [9,12], although
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neither measured energy or macronutrient intake. Thus, it is important to compare race differences in
appetite-related hormones in combination with appetite and laboratory-based food intake assessments.
Such comparisons would elucidate race-related interconnections between appetite-related hormones
and energy intake, providing implications for health disparities related to obesity.
In addition, no study has directly compared the exercise-induced changes in appetite,
appetite-related hormones, food intake, anthropometrics, and body composition in AAs and Whites.
Some showed that AAs lose less weight than Whites during weight loss regimens that include a change
in dietary habits [13], yet the differential effect of exercise alone on weight loss in AAs and Whites is
not known. As exercise is often associated with large inter-individual variability in weight loss [14], it
is important to examine if race modulates this variability. It is also important to assess whether race
alters the change in appetite-related hormones and food intake, since weight loss is a big driver of
changes in appetite-related hormones [15].
Our primary aim was to examine differences in appetite-related hormones, subjective appetite
perceptions, and food intake between AAs and Whites. We hypothesized that, compared to Whites,
AAs would display lower absolute concentrations of leptin, PYY, GLP-1, and ghrelin, as well as blunted
postprandial concentrations of PYY, GLP-1, and ghrelin. Our exploratory aim was to examine race
differences in appetite-related hormones, appetite, food intake, anthropometry, and body composition
in response to a 24-week supervised, controlled aerobic training randomized control trial (RCT).
2. Materials and Methods
2.1. Study Design
The present study is a sub-analysis of AA and White participants who completed the Examination
of Mechanisms of Exercise-Induced Weight Compensation (E-MECHANIC) RCT (ClinicalTrials.gov:
NCT01264406). The Pennington Biomedical Institutional Review Board approved the E-MECHANIC
protocol in 2010 (protocol ID: 10008) and data was collected between November 2010 and December
2015 at Pennington Biomedical Research Center (Baton Rouge, LA, USA). All participants provided
written informed consent, and a data and safety monitoring board supervised the study. Detailed
information about the E-MECHANIC protocol and participant inclusion and exclusion criteria were
reported elsewhere [16]. Healthy adults who were overweight or obese (body mass index (BMI):
≥25 kg/m2 to ≤45 kg/m2), sedentary (not exercising >20 min on ≥3 days/week), not suffering from
cardiometabolic disease, and not currently partaking in any weight loss program were recruited.
Participants were randomized to one of three groups for 24 weeks: a control group that received
health information only, a group that was prescribed an exercise dose recommended for general health
(8 kcal/kg of body weight per week (KKW)), or a group that was prescribed an exercise dose that is
recommended for weight loss and weight loss maintenance (20 KKW) [16]. Exercise was supervised on
a treadmill at a target intensity of 65–85% of peak oxygen uptake (VO2peak), with sessions varying in
length to adhere to the participants’ energy expenditure goals. Energy expenditure rate was measured
to adjust the daily exercise time to account for changes in metabolic or biomechanical efficiency [16].
Participants who identified as AA and White were studied in our analysis. Participants were removed
from analysis because of inadequate energy intake (i.e., less than 15 kJ consumed) or because they did
not complete the study for various reasons, including loss of contact, family issues, or injury.
2.2. Outcome Variables
2.2.1. Anthropometry and Body Composition
At baseline and follow-up, height and body weight were measured with participants wearing only
a weighed clinic gown. Dual-energy X-ray absorptiometry (DXA) (Lunar iDXA and Encore software
version 13.60; GE Healthcare, Madison, WI, USA) was used to examine fat mass, fat-free mass, and fat
percentage at baseline and follow-up.
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2.2.2. Laboratory Food Intake Tests
Participants visited the laboratory at baseline and follow-up to consume a lunch and dinner meal.
Participants were instructed to consume a standardized 190-kcal nutrition bar between 7:00 a.m. and
8:00 a.m. before arriving at the laboratory between 11:00 a.m. and 12:00 p.m. Participants were then
provided with an ad libitum lunch test meal that consisted of sandwiches, potato chips, cookies, and
water. Moreover, participants were provided an option of artificially sweetened or sugar-sweetened
soda or tea [16]. Compared to Whites, a greater proportion of AAs selected sweetened drinks (AAs:
83% vs. Whites: 60%; p < 0.01), whereas a lower percentage selected artificially sweetened drinks
(AAs: 60% vs. Whites: 79%; p = 0.01). Participants returned to the laboratory 5.5 h after the start
of the lunch meal to consume a dinner meal. This contained a buffet meal of 18 high- and low-fat
foods that were used in a previous study [17]. At lunch and dinner, participants were instructed to
consume as much food as they wished. The meals were provided in isolation and participants were
blinded to the purpose of food testing. In between lunch and dinner, with the exception of water,
participants were instructed not to consume any food or beverages. Participants provided verbal
confirmation that they complied with this stipulation. Grams of food and drink consumed were
measured using food scales, and energy and macronutrient consumption was quantified using the
United States Department of Agriculture’s (USDA) Food and Nutrient Database for Dietary Studies
(FNDDS) version 5.0 (ars.usda.gov/ARSUserFiles/80400530/pdf/fndds/fndds5_doc.pdf) [18].
Appetite perceptions were collected immediately before and after lunch and dinner through
validated visual analogue scales (VASs) [19] on computer-based devices. The questions “how hungry
do you feel at this moment”, “how full does your stomach feel at this moment”, “how strong is your
desire to eat at this moment”, “how much food do you think you could eat at this moment”, and
“how satisfied do you feel at this moment” quantified hunger, fullness, desire to eat, prospective food
consumption, and satisfaction, respectively. All VASs were scored 0–100 and contained anchors at
either end. Hunger ratings collected after lunch were expressed as the satiety quotient, which measures
the strength of hunger suppression caused by ingested food and accounts for variations in nutritional
loads [20]. In the current study, the difference in hunger ratings before and after lunch and dinner were
expressed relative to the energy consumed. Specifically, satiety quotient = ((hunger before last meal −
hunger rating at observation point) × 100)/energy intake consumed up to that moment in the day.
Plasma concentrations of PYY, total ghrelin, and GLP-1 were measured before and after the lunch
meal, while serum leptin was measured before lunch only. Whole-blood samples were collected
into ethylenediaminetetraacetic acid (EDTA) tubes from participants in a seated position. A protease
cocktail (50 µL/mL of whole blood) was added to PYY samples and a dipeptidyl peptidase-IV inhibitor
(10 µL/mL of whole blood) was added to GLP-1 collection tubes. Samples were promptly centrifuged
at 3000 rpm for 15 min, and plasma fractions were subsequently aliquoted and stored at −80 ◦C
until analysis. Enzyme-linked immunosorbent assays (ELISAs) were used to measure circulating
concentrations of GLP-1 (Millipore, Watford, UK), and radioimmunoassays (RIAs) were used to
determine PYY, ghrelin, and leptin concentrations (Millipore, Watford, UK).
2.3. Statistical Analysis
Appetite-related hormone concentrations after lunch are presented as delta values to account for
day-to-day variability in appetite-related hormones [21], while the area under the curve (AUC) was
calculated for satiety quotient using the trapezoidal rule [22]. Non-normally distributed data were
log-transformed, yet results did not differ significantly; hence, results from non-transformed data are
reported. To examine race differences in appetite-related hormones, appetite, and food intake, general
linear models were performed comparing AAs and Whites during the baseline period, with age, sex,
and fat mass used as covariates. Energy intake consumed at lunch was an additional covariate for the
delta appetite-related hormones. Two-way unpaired general linear models (race × group) examined
the change in appetitive measures, anthropometry, and body composition from baseline. Baseline
scores were considered a further covariate in these models. Fasting glucose was also included in all
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analyses, although results were not meaningfully altered; therefore, results without this covariate are
reported. Holm–Bonferroni adjusted post hoc t-tests were used to locate variance when significant
F values occurred. Significance for inferential tests was accepted as p < 0.05. Data are displayed as
means ± standard error of the mean (SEM), except for descriptive data, which are presented as means
± SD. Analyses were performed using Statistical Package for the Social Sciences (SPSS) version 24
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Participants
The E-MECHANIC trial enrolled 198 participants at baseline, including 68 AAs and 125 Whites [16].
However, 14 AAs and 13 Whites dropped out, and one AA and one White participant were removed
from all analyses for consuming 0 and 13 kJ, respectively, during a lunch meal at the follow-up visit.
The final analytic sample was therefore comprised of 53 AA and 111 White participants.
In this sample, AAs were younger than Whites (p = 0.02; Table 1). Furthermore, relative VO2peak
was lower, while BMI and fat mass were higher in AAs compared to Whites (p ≤ 0.01). However,
body weight, height, waist circumference, fat-free mass, fat percentage, and fasting blood glucose
concentrations were similar between races (p ≥ 0.06). Unadjusted resting metabolic rate (RMR) did not
differ between races (p = 0.23), although AAs had lower RMR than Whites after accounting for fat-free
mass (p = 0.01; Table 1).
Table 1. Demographics, anthropometry, body composition, peak oxygen uptake, and resting metabolic
rate in African American (AA) and White Examination of Mechanisms of Exercise-Induced Weight
Compensation (E-MECHANIC) participants at baseline.
African American (AA) White p-Value
Age (years) 46.0 ± 10.3 50.4 ± 11.7 0.02
Weight (kg) 92.0 ± 13.5 87.1 ± 16.0 0.06
Height (cm) 165.3 ± 6.9 167.7 ± 8.5 0.08
BMI (kg/m2) 33.4 ± 4.8 30.6 ± 4.3 <0.01
Waist circumference (cm) 98.7 ± 10.5 99.0 ± 13.3 0.87
Fat-free mass (kg) 48.5 ± 8.3 47.8 ± 10.6 0.69
Fat mass (kg) 40.4 ± 11.4 36.4 ± 8.9 0.01
Fat (%) 45.0 ± 8.3 43.2 ± 6.6 0.13
VO2peak (L/min) 1.9 ± 0.5 2.1 ± 0.6 0.08
VO2peak (mL/kg/min) 21.3 ± 5.0 24.3 ± 5.1 <0.01
RMR (kJ/day) 6163 ± 1042 6422 ± 1381 0.23
RMR # (kJ/day) 6121 ± 791 6448 ± 791 0.01
Glucose (mg/dL) 91.5 ± 9.7 93.3 ± 6.5 0.15
Abbreviations: BMI, body mass index; VO2peak, peak oxygen uptake; RMR, resting metabolic rate. Values are means
± SD. # Adjusted for fat-free mass.
3.2. Racial Differences in Appetite-Related Hormones, Appetite, and Food Intake at Baseline
AAs exhibited higher concentrations of leptin (10 ± 3 ng/mL; p < 0.01), and lower concentrations
of PYY (−15 ± 4 pg/mL; p < 0.01) and ghrelin (−192 ± 79 pg/mL; p = 0.02) compared to Whites before
lunch (Figure 1). There were, however, no differences in GLP-1 levels before lunch in AAs and Whites
(−2 ± 1 pg/mL; p = 0.11; Figure 1). After lunch, delta PYY concentrations were 11 ± 4 pg/mL lower in
AAs relative to Whites (p = 0.01), and there was a tendency for lower delta GLP-1 in AAs compared to
Whites (−3 ± 1 pg/mL; p > 0.05), yet racial differences in delta ghrelin (71 ± 47 pg/mL; p = 0.13) were
similar (Figure 2).
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Figure 1. Leptin (A), peptide YY (PYY) (B), ghrelin (C), and glucagon-like peptide-1 (GLP-1) (D) in 
African Americans (AAs) and Whites before lunch during the baseline visit. * Significant difference 
between races (p < 0.05). Values are means ± standard error of the mean (SEM). 
 
Figure 2. Differences in delta peptide YY (PYY) from before lunch (A), delta ghrelin from before lunch 
(B), and delta glucagon-like peptide-1 (GLP-1) from before lunch (C) between African Americans 
(AAs; solid line) and Whites (dashed line) during the baseline visit. * Significant difference between 
races (mean p < 0.05). Values are means ± SEM. 
Ratings for desire to eat (−7 ± 3; p = 0.03) and satisfaction (8 ± 3; p = 0.02) were lower and higher, 
respectively, in AAs than Whites before lunch (Figure 3). Nonetheless, AAs and Whites rated hunger 
(−4 ± 3; p = 0.18), fullness (4 ± 3; p = 0.18), and prospective food consumption (−2 ± 2; p = 0.46) similarly 
before lunch, and the satiety quotient AUC after lunch was not different between races (−2 ± 3; p = 
0.52). 
Figure 1. Leptin (A), peptide YY (PYY) (B), ghrelin (C), and glucagon-like peptide-1 (GLP-1) (D) in
African Americans (AAs) and Whites before lunch during the baseline visit. * Significant difference
between races (p < 0.05). Values are means ± standard error of the mean (SEM).
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Figure 2. Differences in delta peptide YY (PYY) from before lunch (A), delta ghrelin from before lunch
(B), and delta glucagon-like peptide-1 (GLP-1) from before lunch (C) between African Americans (AAs;
solid line) and Whites ( ashed line) during the baseline visit. * Significant diff rence between races
(mean p < 0.05). Values are means ± SEM.
Ratings for desire to e t (−7 ± 3; p = 0.03) and satisfaction (8 ± 3; p = 0.02) were lower and higher,
respectively, in AAs than Whites before lunch (Figure 3). Nonetheless, AAs and Whites rated hunger
(−4 ± 3; p = 0.18), fullness (4 ± 3; p = 0.18), a prospective food consumption (−2 ± 2; p = 0.46)
similarly before lunc , and th satiety quotient AUC after lunch was not differen between rac s
2 3; p = 0.52).
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(E), and satiety quotient area under the curve (AUC) (F) in African Americans (AAs) and Whites 
during the baseline visit. * Significant difference between races (p < 0.05). Values are means ± SEM. 
At baseline, there were no race-related variations in energy intake at lunch (130 ± 203 kJ; p = 0.52), 
dinner (13 ± 258 kJ; p = 0.96), and lunch and dinner combined (168 ± 393 kJ; p = 0.67; Figure 4). 
Likewise, cumulatively, AAs vs. Whites consumed comparable amounts of carbohydrate (21 ± 13 g; 
p = 0.11), fat (−3 ± 4 g; p = 0.51), and protein (−3 ± 4 g; p = 0.47; Figure 4), with no differences in 
macronutrient consumption at lunch or dinner separately (Figure S1, Supplementary Materials). 
Figure 3. Hunger (A), fullness (B), desire to eat (C), prospective food consumption (D), satisfaction (E),
and satiety quotient area under the curve (AUC) (F) in African Americans (AAs) and Whites during
the baseline visit. * Significant difference between races (p < 0.05). Values are means ± SEM.
At baseline, there were no race-related variations in energy intake at lunch (130 ± 203 kJ; p = 0.52),
dinner (13 ± 258 kJ; p = 0.96), and lunch and dinner combined (168 ± 393 kJ; p = 0.67; Figure 4).
Likewise, cumulatively, AAs vs. Whites consumed comparable amounts of carbohydrate (21 ± 13
g; p = 0.11), fat (−3 ± 4 g; p = 0.51), and protein (−3 ± 4 g; p = 0.47; Figure 4), with no differences in
macronutrient consumption at lunch or dinner separately (Figure S1, Supplementary Materials).
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Figure 4. Lunch energy intake (A), dinner energy intake (B), total energy intake (C), total carbohydrate
intake (D), total protein intake (E), and total fat intake (F) between African Americans (AAs) and Whites
during the baseline visit. No significant differences between races were observed (p ≥ 0.05). Values are
means ± SEM.
3.3. Racial Variations in Appetite-Related Hormones, Appetite, and Food Intake in Response to Exercise
In response to exercise, there were no main effects of race (p ≥ 0.11), group (p ≥ 0.65), or
race-by-group interactions (p ≥ 0.36) for changes in PYY, ghrelin, and GLP-1 concentrati ns b fore
lunch (Figure 5). However, there was a significant race-by-group interactio for change in leptin
(p = 0.01). Post hoc analysis demonstrated th t the 8 KKW group displayed 13 ± 4 ng/mL increase
in leptin concentrations compared to the control group in AAs (p = 0.01) but not Whites (p = 0.60;
Figure 5).
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peptide-1 (J–L) in African Americans (AAs) and Whites at baseline and after the exercise intervention 
in the control, 8 kcal/kg of body weight/week (KKW), and the 20 KKW groups before lunch. White 
bars represent African Americans at baseline; light grey bars represent African Americans at the end 
of the intervention; black bars represent Whites at baseline; dark grey bars represent Whites at the 
end of the intervention. * Significant two-way interaction between race and group for change score, 
as examined by a two-way unpaired general linear model, controlling for baseline (p < 0.05). Values 
are means ± SEM. 
The changes in delta concentrations of PYY, GLP-1, and ghrelin after lunch were not influenced 
by race (main effect of race; p ≥ 0.13), group (main effect of group; p ≥ 0.43), or by the interaction 
between race and group (p ≥ 0.06) in response to exercise (Figure 6). 
Figure 5. Concentrations of leptin (A–C), peptide YY (PYY) (D–F), ghrelin (G-I), and
glucagon-like-peptide-1 (J–L) in African Americans (AAs) and Whites at baseline and after the
exercise intervention in the control, 8 kcal/kg of body weight/week (KKW), and the 20 KKW groups
before lunch. White bars represent African Americans at baseline; light grey bars represent African
Americans at the end of the intervention; black bars represent Whites at baseline; dark grey bars
represent Whites at the end of the intervention. * Significant two-way interaction between race and
group for change score, as examined by a two-way unpaired general linear model, controlling for
baseline (p < 0.05). Values are means ± SEM.
The changes in delta concentrations of PYY, GLP-1, and ghrelin after lunch were not influenced by
race (main effect of race; p ≥ 0.13), group (main effect of group; p ≥ 0.43), or by the interaction between
race and group (p ≥ 0.06) in response to exercise (Figure 6).
There was a main effect of race for changes in hunger and satiety quotient AUC, with AAs showing
a decrease in hunger (−7 ± 3; p = 0.03) and satiety quotient AUC (−11 ± 4; p = 0.02) compared to Whites,
but changes in other appetite perceptions were similar between races (p ≥ 0.17; Table 2). Additionally,
there was a main effect of group (p = 0.03) for prospective food consumption, whereby ratings of
prospective food consumption increased in the control group relative to the 20 KKW group (7 ± 3;
p = 0.03; Table 2). No other group differences were seen (p ≥ 0.33), and no race-by-group interactions
were observed for all appetite perceptions (p ≥ 0.08; Table 2).
Changes in lunch energy intake, dinner energy intake, and total energy intake were not affected by
race (main effect of race; p ≥ 0.11), group (main effect of group; p ≥ 0.11), or a race-by-group interaction
(p ≥ 0.09; Table 2). Apart from protein intake at dinner, where AAs consumed less than Whites after the
intervention (main effect of race; p = 0.04; Table S1, Supplementary Materials), the changes in lunch,
dinner, and total intake of carbohydrate, fat, and protein intake showed no main effects of race (p ≥
0.11) and group (p ≥ 0.08), and no race-by-group interactions (p ≥ 0.05; Table 2).
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Figure 6. Differences in delta peptide YY (PYY) from before lunch (A–C), delta ghrelin from before
lunch (D–F), and d lta glucagon-like-peptide-1 (GLP-1) from before lunch (G–I) b tween African
Americans (AAs; solid line) and Whit s (dash d line) at baseline (open cir le) and aft r th exercise
intervention (dark quare) in the control, 8 KKW, and the 20 KKW groups. No significant diff ren e
between races and gro p were observed for change score, as examined by a two-way unpaired general
linear model, controlling for bas line (p ≥ 0.05). Values are mean ± SEM.
3.4. Racial Variations in Anthropometry and Body Composition in Response to Exercise
There were no ain race (p = 0.96) or race-by-group interaction effects (p = 0.30) for weight change
(Table 3). A main effect of group was identified for weight change (p = 0.04), although there was only a
tendency for increased weight loss in the 20 KKW group compared to the control group after post
hoc adjustments (20 KKW group: −1.9 ± 0.5 kg vs. control: −0.4 ± 0.4 kg; p > 0.05). Change in waist
circumference was not influenced by race (main effect of race; p > 0.99), group (main effect of group; p
= 0.23), or a race-by-group interaction (p = 0.21; Table 3).
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Table 2. Changes in subjective appetite and food intake in response to the 24-week intervention in Africans Americans and Whites.
African American (AA) White
Control (n = 20) 8 KKW (n = 20) 20 KKW (n = 13) Control (n = 37) 8 KKW (n = 38) 20 KKW (n = 36)
Hunger before lunch 3 (4) a −2 (4) a −1 (5) a 7 (3) 10 (3) 2 (3)
Fullness before lunch 0 (4) 4 (4) −4 (5) −3 (3) −6 (3) 4 (3)
Prospective food
consumption before lunch 9 (3) 3 (3) 0 (4)
b 6 (2) 7 (2) 0 (2) b
Desire to eat before lunch 9 (4) 1 (4) 2 (5) 4 (3) 7 (3) 3 (3)
Satisfaction before lunch −12 (4) −3 (4) −7 (5) −3 (3) −7 (3) 2 (3)
Satiety quotient AUC −1 (6) a −9 (6) a −5 (7) a 10 (4) 8 (4) 1 (4)
Lunch energy intake (kJ) 213 (18) 161 (184) −174 (221) −360 (132) 197 (132) −133 (133)
Dinner energy intake (kJ) −779 (287) −783 (299) −258 (351) −160 (213) −299 (210) −277 (212)
Total energy intake (kJ) −525 (362) −861 (370) −423 (444) −521 (266) −120 (264) −409 (268)
Total carbohydrate intake (g) −11 (11) −11 (12) −7 (14) −16 (8) 1 (8) −8 (9)
Total protein intake (g) −7 (4) −15 (4) −9 (5) −7 (3) −3 (3) −6 (3)
Total fat intake (g) −6 (4) −11 (4) −4 (5) −4 (3) −3 (3) −5 (3)
Abbreviations: KKW, kcal/kg of body weight/week; AUC, area under the curve. a Significant difference between African Americans and Whites (main effect of race; p ≤ 0.03); b significant
difference between 20 KKW group and control (main effect of group; p = 0.03). Values are means ± standard error of the mean (SEM).
Table 3. Changes in anthropometric and body composition measures in response to the 24-week intervention in Africans Americans and Whites.
African American (AA) White
Control (n = 20) 8 KKW (n = 20) 20 KKW (n = 13) Control (n = 37) 8 KKW (n = 38) 20 KKW (n = 36)
Weight (kg) 0.2 (0.7) −0.7 (0.7) −2.1 (0.8) −0.9 (0.5) −0.2 (0.5) −1.6 (0.5)
Waist circumference (cm) −0.1 (0.9) −0.8 (0.9) −2.3 (1.1) −1.7 (0.6) −0.1 (0.6) −1.4 (0.6)
Fat-free mass (kg) −0.1 (0.3) 0.0 (0.3) −0.3 (0.3) −0.6 (0.2) −0.2 (0.2) −0.3 (0.2)
Fat mass (kg) 0.1 (0.6) −0.9 (0.6) −2.1 (0.7) a −0.4 (0.4) −0.1 (0.4) −1.4 (0.4) a
Fat percentage (%) −0.1 (0.4) −0.5 (0.4) −1.4 (0.5) b −0.1 (0.3) 0.0 (0.3) −0.8 (0.3) b
Abbreviations: KKW, kcal/kg of body weight/week. a Significant difference between the 20 KKW group and the control and 8 KKW groups (main effect of group; p ≤ 0.05); b significant
difference between the 20 KKW group and the control group (main effect of group; p ≤ 0.05). Values are means ± SEM.
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Changes in fat-free mass (p = 0.22), fat mass (p = 0.47), and fat percentage (p = 0.29) were similar
in AAs and Whites (main effect of race), and no race-by-group interactions were identified for these
measures (p ≥ 0.36). There was, by contrast, a main effect of group for fat mass (p = 0.01), with the
20 KKW group showing a greater loss of fat mass compared to the 8 KKW (−1.2 ± 0.5 kg; p = 0.04) and
control (−1.6 ± 0.5 kg; p = 0.01) groups. Similarly, there was a main effect of group for change in fat
percentage (p = 0.03). Post hoc comparisons revealed that the 20 KKW group displayed a decrease in
fat percentage relative to the control group (−1.0 ± 0.4%; p = 0.03).
4. Discussion
Our primary objective was to examine racial differences in appetite-related hormones, appetite
perceptions, and food intake. Our analysis showed that AAs exhibited higher leptin concentrations,
lower concentrations of PYY and ghrelin, and lower desire to eat and higher satisfaction compared to
Whites before lunch at baseline. However, no differences were observed for GLP-1 concentrations,
and no differences in energy or macronutrient intake were seen during ad libitum test meals. Delta
PYY after lunch was blunted in AAs relative to Whites, although changes in ghrelin and GLP-1 were
similar between racial groups. As an exploratory aim, we investigated race differences in appetitive
measures, anthropometry, and body composition in response to a 24-week aerobic training RCT.
Overall, despite AAs in the 8 KKW group showing higher changes in leptin compared to the control
group, race and exercise group did not appreciably alter appetite-related hormones in response to the
exercise intervention. Race and exercise group also did not interact to affect appetite-related hormones,
subjective appetite, or food intake, and both races displayed similar body composition changes during
the exercise trial.
It has been postulated that differences in concentrations of appetite-related hormones may
contribute to the greater obesity risk in AAs [12,23], but there is limited evidence that has examined
whether racial variations in these hormones translate into meaningful changes in appetitive measures.
We found that AAs presented lower concentrations of PYY, further to a blunted elevation in PYY in
response to food intake compared to Whites. Attenuated concentrations of PYY are related to reduced
satiety [24], yet satiety was not different between AAs and Whites at our baseline visit. Our results also
show that AAs had lower desire to eat and higher satisfaction than Whites before lunch, although the
mean difference was modest and thus the clinical relevance of these differences could be questioned [25].
In addition to appetite, we saw no differences between AAs and Whites in energy and macronutrient
consumption during our test meal day. Some studies indicated that a lower reduction in concentrations
of PYY is related to an increase in energy intake and energy-dense foods [21,26], though our results
contradict this. Inconsistent associations between appetite-related hormones and appetite and energy
intake have been reported [27,28], questioning the influence of appetite-related hormones on food
intake. This is supported by studies in humans which showed that appetite-related hormones trigger
no changes in appetite or food intake when infused at physiological levels [29,30]. Nevertheless, given
the plethora of biological appetite-related agents, it is possible that other appetite-related hormones
counteract the variations in PYY between AAs and Whites, meaning appetite and food intake measures
remain similar between races [31].
Our results suggest that AAs display lower ghrelin concentrations and higher leptin concentrations.
Brownley et al. [7] reported that leptin concentrations are higher in AAs, supporting our findings,
although studies assessing ghrelin variations in AAs and Whites have been mixed. Some work
indicated that lower ghrelin concentrations are evident in AAs compared to Whites [9,10], whereas
others showed the contrary [7]. It is possible that contrasting findings are due to discrepancies in
controlling body composition, which affects ghrelin concentrations [32]. This could have particular
ramifications in AAs as this racial group displays a large degree of variability in body fat percentage
for a given BMI [33]. The consequences of lower ghrelin and higher leptin levels in AAs are unclear.
However, since resistance to the metabolic actions of both of these hormones is thought to contribute
to the development and maintenance of obesity [34], racial disparities in obesity could be influenced
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by variations in the sensitivity to leptin and ghrelin, with AAs showing lower sensitivity than Whites.
Moreover, lower ghrelin and higher leptin levels are associated with poorer regulation of blood glucose
regulation, insulin resistance, and lower metabolic flexibility [35,36]. Thus, differences in ghrelin and
leptin between AAs and Whites could play a role in the elevated cardiometabolic risk demonstrated by
AAs relative to Whites [37].
To our knowledge, our study represents the first study to examine differences in GLP-1 between
AAs and Whites. In contrast to other appetite-related hormones, we did not observe any differences
in absolute or postprandial concentrations of GLP-1 between AAs and Whites, although there was a
tendency for AAs to exhibit lower rises in GLP-1 after lunch. It is possible that the short half-life of
GLP-1 makes it difficult to detect differences in concentrations between AAs and Whites from venous
blood [11]. One study recently showed that venous concentrations of GLP-1 are smaller and less
physiologically relevant from an appetite perspective than those yielded from arterialized blood [38].
As a result, future studies may benefit from performing assessments of arterialized concentrations of
GLP-1 to observe differences between AAs and Whites.
Our assessments of appetite and energy intake collectively infer that variations in appetite-related
hormones and satiety are not likely to play a role in the increased obesity risk shown in AAs. It is likely
that other physiological disparities, including lower basal metabolic rate and aerobic fitness [39,40],
may be more pivotal in explaining the elevated obesity risk in AAs. Indeed, AAs demonstrated
suppressed RMR after adjusting for body composition and lower VO2peak values than Whites in our
cohort, implying that alterations in energy expenditure and fitness may be more crucial in mediating
race-related obesity disparities than differences in appetitive outcomes. Nonetheless, in spite of similar
energy and macronutrient intake between races, additional work is needed to examine race-related
variations in food and beverage choices, particularly as this and previous work [41] indicated that
beverage selection could be different between races.
Intriguingly, in response to exercise, we found that the 8 KKW group showed an increase in leptin
concentrations compared to the control group in AAs but not Whites. Leptin concentrations have been
shown to decrease during exercise training [42], and this is likely to be driven by exercise-induced
reductions in body fat, which is a potent modulator of leptin concentrations [43]. Nevertheless,
there were no variations in body fat between the 8 KKW group and control group in response to
exercise and no differences between AAs and Whites. The reasons for our race-by-group interaction
in leptin concentrations are therefore difficult to interpret, and further studies may be required. In
spite of racial differences in leptin, the 8 KKW and 20 KKW exercise interventions engendered similar
changes in PYY, ghrelin, and GLP-1 concentrations in AAs and Whites. Furthermore, there were no
race-by-group interactions seen for appetite, energy intake, and macronutrient intake, expanding upon
previous evidence reporting similar changes in energy intake between AAs and Whites after regimens
incorporating dietary changes [13]. We similarly detected no differences between AAs and Whites
in body weight changes to exercise. Previous work documented that AAs show attenuated weight
loss compared to Whites in interventions that integrate dietary and physical activity modifications;
however, these studies induced greater reductions in body fat than were stimulated in our trial [13].
Although this could be expected as exercise per se stimulates small weight loss [44], it is possible that
racial differences in appetitive, anthropometric, and body composition outcomes are evident during
efficacious weight loss regimens. This may be particularly pertinent for PYY, ghrelin, and GLP-1, since
lower adiposity is associated with higher plasma concentrations of these peptides [26,45,46].
A strength of our study was the validated measures to determine appetite and energy intake. Our
trial was also a randomized controlled trial, with controlled, supervised exercise sessions to ensure
the appropriate exercise dose was administered to participants. One limitation of our study is that
73% our sample consisted of women. Consequently, although sex was a covariate in our analysis,
our results may primarily be inferred to racial variations in women, indicating that further studies
with larger samples of AA and White men are needed. Another limitation is that our study only
assessed four appetite-related peptides. Future studies should examine differences in postprandial
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glucose and other appetite-related hormones such as insulin, oxyntomodulin, amylin, and pancreatic
polypeptide between AAs and Whites in order to elucidate how race influences the appetite-related
hormone milieu.
5. Conclusions
In summary, compared to Whites, AAs display lower concentrations of PYY and a suppressed
change in PYY after food intake. Plasma concentrations of leptin and ghrelin were also higher and lower,
respectively, in AAs than Whites independent of fat mass. However, variations in laboratory-based
energy and macronutrient intake were not seen. We additionally showed that appetitive measures,
anthropometry, and body composition were not appreciably affected by the interaction between race
and exercise. While additional studies are needed to ascertain the metabolic consequences of racial
differences in appetite-related hormones, differences between AAs and Whites in appetite-related
hormones appeared not to influence racial disparities in obesity risk in the current trial.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/9/2018/s1,
Figure S1: Differences in lunch carbohydrate intake, dinner carbohydrate intake, lunch fat intake, dinner fat
intake, lunch protein intake, and dinner protein intake between African Americans (AAs) and Whites during the
baseline visit. No significant differences between races were observed (p ≥ 0.05). Values are means ± SEM, Table
S1: Changes in appetite-related hormones and food intake in response to the intervention in Africans Americans
and Whites.
Author Contributions: J.L.D., J.W.A., T.S.C., and C.K.M., conception and design, data collection and analysis,
manuscript writing, and final approval of the manuscript; C.A.M., C.H., D.S.H., and U.A.W. reviewed, edited, and
approved the manuscript. All authors critically appraised, edited, and approved the manuscript.
Funding: Research reported in this publication was supported by the National Institutes of Health via the National
Heart, Lung, And Blood Institute with the multiple principal investigators being C. Martin and T. Church (R01
HL102166); the NORC Center Grant P30 DK072476, entitled “Nutritional Programming: Environmental and
Molecular Interactions” sponsored by NIDDK; the National Institute of General Medical Sciences, which funds
the Louisiana Clinical and Translational Science Center (U54 GM104940); and NIH grant F32 HL123242.
Acknowledgments: The authors would like to thank participants for their time and commitment to the study.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Cossrow, N.; Falkner, B. Race/ethnic issues in obesity and obesity-related comorbidities. J. Clin. Endocrinol.
Metab. 2004, 89, 2590–2594. [CrossRef] [PubMed]
2. Flegal, K.M.; Carroll, M.D.; Ogden, C.L.; Curtin, L.R. Prevalence and trends in obesity among US adults,
1999–2008. JAMA J. Am. Med. Assoc. 2010, 288, 1723–1727. [CrossRef] [PubMed]
3. Slack, T.; Myers, C.A.; Martin, C.K.; Heymsfield, S.B. The geographic concentration of US adult obesity
prevalence and associated social, economic, and environmental factors. Obesity 2014, 22, 868–874. [CrossRef]
[PubMed]
4. Mensah, G.A.; Mokdad, A.H.; Ford, E.S.; Greenlund, K.J.; Croft, J.B. State of disparities in cardiovascular
health in the United States. Circulation 2005, 111, 1233–1241. [CrossRef] [PubMed]
5. Carpenter, W.H.; Fonong, T.; Toth, M.J.; Ades, P.A.; Calles-Escandon, J.; Walston, J.D.; Poehlman, E.T. Total
daily energy expenditure in free-living older African-Americans and Caucasians. Am. J. Physiol. Metab. 1998,
274, E96–E101. [CrossRef] [PubMed]
6. Weinsier, R.L.; Hunter, G.R.; Zuckerman, P.A.; Redden, D.T.; Darnell, B.E.; Larson, D.E.; Newcomer, B.R.;
Goran, M.I. Energy expenditure and free-living physical activity in black and white women: Comparison
before and after weight loss. Am. J. Clin. Nutr. 2000, 71, 1138–1146. [CrossRef] [PubMed]
7. Brownley, K.A.; Light, K.C.; Grewen, K.M.; Bragdon, E.E.; Hinderliter, A.L.; West, S.G. Postprandial ghrelin
is elevated in black compared with white women. J. Clin. Endocrinol. Metab. 2004, 89, 4457–4463. [CrossRef]
[PubMed]
8. Davis, J.; Hickner, R.C.; Tanenberg, R.J.; Barakat, H. Peptide-YY levels after a fat load in black and white
women. Obes. Res. 2005, 13, 2055–2057. [CrossRef] [PubMed]
Nutrients 2019, 11, 2018 14 of 16
9. Brownley, K.A.; Heymen, S.; Hinderliter, A.L.; Galanko, J.; MacIntosh, B. Low-glycemic load decreases
postprandial insulin and glucose and increases postprandial ghrelin in white but not black women. J. Nutr.
2012, 142, 1240–1245. [CrossRef] [PubMed]
10. Araneta, M.R.G.; Barrett-Connor, E. Adiponectin and ghrelin levels and body size in normoglycemic Filipino,
African-American, and white women. Obesity 2007, 15, 2454–2462. [CrossRef] [PubMed]
11. Holst, J.J. The physiology of glucagon-like peptide 1. Physiol. Rev. 2007, 87, 1409–1439. [CrossRef] [PubMed]
12. Brownley, K.A.; Heymen, S.; Hinderliter, A.L.; MacIntosh, B. Effect of glycemic load on peptide-yy levels in a
biracial sample of obese and normal weight women. Obesity 2010, 18, 1297–1303. [CrossRef] [PubMed]
13. Delany, J.P.; Jakicic, J.M.; Lowery, J.B.; Hames, K.C.; Kelley, D.E.; Goodpaster, B.H. African American women
exhibit similar adherence to intervention but lose less weight due to lower energy requirements. Int. J. Obes.
2014, 38, 1147–1152. [CrossRef] [PubMed]
14. King, N.A.; Hopkins, M.; Caudwell, P.; Stubbs, R.J.; Blundell, J.E. Individual variability following 12 weeks
of supervised exercise: Identification and characterization of compensation for exercise-induced weight loss.
Int. J. Obes. 2008, 32, 177–184. [CrossRef] [PubMed]
15. Dorling, J.; Broom, D.R.; Burns, S.F.; Clayton, D.J.; Deighton, K.; James, L.J.; King, J.A.; Miyashita, M.;
Thackray, A.E.; Batterham, R.L.; et al. Acute and chronic effects of exercise on appetite, energy intake, and
appetite-related hormones: The modulating effect of adiposity, sex, and habitual physical activity. Nutrients
2018, 10, 1140. [CrossRef] [PubMed]
16. Myers, C.A.; Johnson, W.D.; Earnest, C.P.; Rood, J.C.; Tudor-Locke, C.; Johannsen, N.M.; Cocreham, S.;
Harris, M.; Church, T.S.; Martin, C.K. Examination of mechanisms (E-MECHANIC) of exercise-induced
weight compensation: Study protocol for a randomized controlled trial. Trials 2014, 2014, 212. [CrossRef]
[PubMed]
17. Martin, C.K.; Coulon, S.M.; Markward, N.; Greenway, F.L.; Anton, S.D. Association between energy intake
and viewing television, distractibility, and memory for advertisements. Am. J. Clin. Nutr. 2009, 89, 37–44.
[CrossRef] [PubMed]
18. Ahuja, J.K.C.; Montville, J.B.; Omolewa-tomobi, G.; Heendeniya, K.Y.; Martin, C.L.; Steinfeldt, L.C.; Anand, J.;
Adler, M.E.; Lacomb, R.P.; Moshfegh, A.J. The USDA Food and Nutrient Database for Dietary Studies, 5.0.
Available online: https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/fndds/fndds5_doc.pdf (accessed on
20 August 2012).
19. Flint, A.; Raben, A.; Blundell, J.E.; Astrup, A. Reproducibility, power and validity of visual analogue scales
in assessment of appetite sensations in single test meal studies. Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc.
Study Obes. 2000, 24, 38–48. [CrossRef]
20. Green, S.M.; Delargy, H.J.; Joanes, D.; Blundell, J.E. A satiety quotient: A formulation to assess the satiating
effect of food. Appetite 1997, 29, 291–304. [CrossRef]
21. Karra, E.; Daly, O.G.O.; Choudhury, A.I.; Yousseif, A.; Millership, S.; Neary, M.T.; Scott, W.R.; Chandarana, K.;
Manning, S.; Hess, M.E.; et al. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J.
Clin. Investig. 2013, 123, 1–13. [CrossRef]
22. Doucet, E.; St-Pierre, S.; Alméras, N.; Tremblay, A. Relation between appetite ratings before and after a
standard meal and estimates of daily energy intake in obese and reduced obese individuals. Appetite 2003,
40, 137–143. [CrossRef]
23. Cooper, J.A. Factors affecting circulating levels of peptide YY in humans: A comprehensive review. Nutr.
Res. Rev. 2014, 27, 186–197. [CrossRef] [PubMed]
24. Batterham, R.L.; Heffron, H.; Kapoor, S.; Chivers, J.E.; Chandarana, K.; Herzog, H.; Le Roux, C.W.;
Thomas, E.L.; Bell, J.D.; Withers, D.J. Critical role for peptide YY in protein-mediated satiation and
body-weight regulation. Cell Metab. 2006, 4, 223–233. [CrossRef] [PubMed]
25. Blundell, J.; De Graaf, C.; Hulshof, T.; Jebb, S.; Livingstone, B.; Lluch, A.; Mela, D.; Salah, S.; Schuring, E.; Van
Der Knaap, H.; et al. Appetite control: Methodological aspects of the evaluation of foods. Obes. Rev. 2010,
11, 251–270. [CrossRef] [PubMed]
26. Batterham, R.L.; Cohen, M.A.; Ellis, S.M.; Le Roux, C.W.; Withers, D.J.; Frost, G.S.; Ghatei, M.A.; Bloom, S.R.
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36. N. Engl. J. Med. 2003, 349, 941–948.
[CrossRef] [PubMed]
Nutrients 2019, 11, 2018 15 of 16
27. Gibbons, C.; Caudwell, P.; Finlayson, G.; Webb, D.L.; Hellström, P.M.; Näslund, E.; Blundell, J.E. Comparison
of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate
and their association with hunger and the phases of satiety. J. Clin. Endocrinol. Metab. 2013, 98, E847–E855.
[CrossRef]
28. Clayton, D.J.; Burrell, K.; Mynott, G.; Creese, M.; Skidmore, N.; Stensel, D.J.; James, L.J. Effect of 24-h severe
energy restriction on appetite regulation and ad libitum energy intake in lean men and women1,2. Am. J.
Clin. Nutr. 2016, 104, 1545–1553. [CrossRef]
29. Lippl, F.; Erdmann, J.; Steiger, A.; Lichter, N.; Czogalla-Peter, C.; Bidlingmaier, M.; Tholl, S.; Schusdziarra, V.
Low-dose ghrelin infusion—Evidence against a hormonal role in food intake. Regul. Pept. 2012, 174, 26–31.
[CrossRef]
30. Degen, L.; Oesch, S.; Casanova, M.; Graf, S.; Ketterer, S.; Drewe, J.; Beglinger, C. Effect of peptide YY3-36 on
food intake in humans. Gastroenterology 2005, 129, 1430–1436. [CrossRef]
31. Begg, D.P.; Woods, S.C. The endocrinology of food intake. Nat. Rev. Endocrinol. 2013, 9, 584–597. [CrossRef]
32. Tai, K.; Visvanathan, R.; Hammond, A.J.; Wishart, J.M.; Horowitz, M.; Chapman, I.M. Fasting ghrelin is
related to skeletal muscle mass in healthy adults. Eur. J. Nutr. 2009, 48, 176–183. [CrossRef]
33. Lovejoy, J.C.; Smith, S.R.; Rood, J.C. Comparison of regional fat distribution and health risk factors in
middle-aged white and African American women: The healthy transitions study. Obes. Res. 2001, 9, 10–16.
[CrossRef]
34. Cui, H.; López, M.; Rahmouni, K. The cellular and molecular bases of leptin and ghrelin resistance in obesity.
Nat. Rev. Endocrinol. 2017, 13, 338–351. [CrossRef]
35. Scherer, T.; Buettner, C. Yin and Yang of hypothalamic insulin and leptin signaling in regulating white
adipose tissue metabolism. Rev. Endocr. Metab. Disord. 2011, 12, 235–243. [CrossRef]
36. Longo, K.A.; Charoenthongtrakul, S.; Giuliana, D.J.; Govek, E.K.; McDonagh, T.; Qi, Y.; DiStefano, P.S.;
Geddes, B.J. Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul.
Pept. 2008, 150, 55–61. [CrossRef]
37. Menke, A.; Casagrande, S.; Geiss, L.; Cowie, C.C. Prevalence of and trends in diabetes among adults in the
United States, 1988–2012. JAMA J. Am. Med. Assoc. 2015, 314, 1021–1029. [CrossRef]
38. Chen, Y.C.; Edinburgh, R.M.; Hengist, A.; Smith, H.A.; Walhin, J.P.; Betts, J.A.; Thompson, D.; Gonzalez, J.T.
Venous blood provides lower glucagon-like peptide-1 concentrations than arterialized blood in the
postprandial but not the fasted state: Consequences of sampling methods. Exp. Physiol. 2018, 103,
1200–1205. [CrossRef]
39. Shook, R.P.; Hand, G.A.; Wang, X.; Paluch, A.E.; Moran, R.; Hébert, J.R.; Swift, D.L.; Lavie, C.J.; Blair, S.N.
Low fitness partially explains resting metabolic rate differences between African American and white women.
Am. J. Med. 2014, 127, 436–442. [CrossRef]
40. Katzmarzyk, P.T.; Most, J.; Redman, L.M.; Rood, J.; Ravussin, E. Energy expenditure and substrate oxidation
in White and African American young adults without obesity. Eur. J. Clin. Nutr. 2018, 72, 920–922. [CrossRef]
41. Park, S.; Blanck, H.M.; Sherry, B.; Brener, N.; O’Toole, T. Factors associated with sugar-sweetened beverage
intake among United States high school students. J. Nutr. 2012, 142, 306–312. [CrossRef]
42. Guelfi, K.J.; Donges, C.E.; Duffield, R. Beneficial effects of 12 weeks of aerobic compared with resistance
exercise training on perceived appetite in previously sedentary overweight and obese men. Metabolism 2013,
62, 235–243. [CrossRef]
43. Considine, R.V.; Sinha, M.K.; Heiman, M.L.; Kriauciunas, A.; Stephens, T.W.; Nyce, M.R.; Ohannesian, J.P.;
Marco, C.C.; McKee, L.J.; Bauer, T.L.; et al. Serum immunoreactive leptin concentrations in normal-weight
and obese humans. N. Engl. J. Med. 1996, 334, 292–295. [CrossRef]
44. Martin, C.K.; Johnson, W.D.; Myers, C.A.; Apolzan, J.W.; Earnest, C.P.; Thomas, D.M.; Rood, J.C.;
Johannsen, N.M.; Tudor-Locke, C.; Harris, M.; et al. Effect of different doses of supervised exercise
on food intake, metabolism, and non-exercise physical activity: The E-MECHANIC randomized controlled
trial. Am. J. Clin. Nutr. 2019. [CrossRef]
Nutrients 2019, 11, 2018 16 of 16
45. Faerch, K.; Torekov, S.S.; Vistisen, D.; Johansen, N.B.; Witte, D.R.; Jonsson, A.; Pedersen, O.; Hansen, T.;
Lauritzen, T.; Sandbaek, A.; et al. GLP-1 response to oral glucose is reduced in prediabetes, screen-detected
type 2 diabetes, and obesity and influenced by sex: The ADDITION-PRO Study. Diabetes 2015, 64, 2513–2525.
[CrossRef]
46. Tschöp, M.; Weyer, C.; Tataranni, P.A.; Devanarayan, V.; Ravussin, E.; Heiman, M.L. Circulating ghrelin
levels are decreased in human obesity. Diabetes 2001, 50, 707–709. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
